Combination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta-Analysis - ScienceDirect
Respuestas para un nuevo abordaje de la hepatitis C
Figure 4, Illustration of the Sensitivity of LDV/SOF Sustained Virologic Response to One (LDV/SOF 22/1) and Two (LDV/SOV 22/2) Additional Data Points - Ledipasvir/Sofosbuvir (Harvoni) - NCBI Bookshelf
Treatment groups by regimen. SOF, sofosbuvir; LDV, ledipasvir; SIM,... | Download Scientific Diagram
Effectiveness of Ledipasvir/Sofosbuvir with/without Ribavarin in Liver Transplant Recipients with Hepatitis C
ION-3 Study: LDV/SOF + RBV for naïve genotype 1 - ppt download
Informe de Posicionamiento Terapéutico de ledipasvir/sofosbuvir (Harvoni®)
Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study | BMJ Open
Efficacy and tolerability of interferon‑free regimen for patients with genotype‑1 HCV infection
Incremental cost and effectiveness of SOF/LDV and SOF/VEL relative to... | Download Scientific Diagram
Combinación de ledipasvir/sofosbuvir como tratamiento de la infección crónica por hepatitis C | Anales de Pediatría
EVALUACIÓN DE LA EFICACIA DE NUEVOS ANTIVÍRICOS DE ACCIÓN DIRECTA EN COMBINACIÓN CON SOFOSBUVIR FRENTE A GENOTIPO 1 DE VHC
Forest plot of relative risks of not achieving SVR12 with 12 weeks of... | Download Scientific Diagram
Resistencias al virus de la hepatitis C. Implicaciones y posibilidades terapéuticas | Gastroenterología y Hepatología
Assessment of treatment options for patients with hepatitis C virus recombinant form 2k/1b - Zakalashvili - 2021 - Hepatology Research - Wiley Online Library
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study | PLOS ONE
Real-world effectiveness of 8-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C - ScienceDirect
Informe de Posicionamiento Terapéutico de ledipasvir/sofosbuvir (Harvoni®)
EVALUACION DE LA EFICACIA Y SEGURIDAD DE LOS TRATAMIENTOS CON LOS NUEVOS ANTIVIRALES DIRECTOS DEL VHC EN PACIENTES COINFECTADOS
Tractament antiviral de l'hepatitis C crònica a l'any 2019, 2020 i 2021
Cost-utility Analysis of Second-generation Direct-acting Antivirals for Hepatitis C | Hepatitis Monthly | Full Text
Informe de Posicionamiento Terapéutico de ledipasvir/sofosbuvir (Harvoni®)
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
Treatment outcomes for SOF/LDV without RBV for HCV genotype 1 (1a, 1b,... | Download Scientific Diagram
